"Human Trial: Injecting Cells to Grow New Livers from Lymph Nodes"

A biotech company has successfully dosed a human patient with a cocktail of donated liver cells in a Phase 2a clinical trial, aiming to transform a lymph node into a functioning liver. This experimental treatment could provide relief to patients with end-stage liver disease who are unable to receive transplants. By using discarded livers and injecting a small number of hepatocytes into lymph nodes, the researchers hope to address the shortage of organ donations. While successful in animal studies, uncertainties remain about the number of cells needed for a functioning liver in humans. If successful, this approach could potentially help balance the supply and demand of organs for patients in need.